MEDVAL and NuQuest Come Together as IMPAXX

Medicare Secondary Payer (MSP) Compliance pioneers MEDVAL and NuQuest announced today that they will expand their product and service portfolios and enhance their customer systems by joining forces as IMPAXX. The move allows IMPAXX to address ongoing demand for MSP compliance and reporting products and services while focusing on leveraging analytics and technology to drive innovation.

Full integration of the two organizations is complete and products and services will be provided under the IMPAXX name. Barbara Fairchild and Jon Gunter will lead IMPAXX as Co-Chief Executive Officers.

“We have been sister companies for the past several years, and during that time our respect for one another’s strengths continued to grow,” stated Barbara Fairchild, CEO for IMPAXX. “It became apparent that we could create even more value for our customers by combining our experience and capabilities and concentrating on developing forward-thinking products and services.”

From Medicare-Set Asides and Cost Projections to Section 111 Reporting and Lien Resolution, IMPAXX will offer a variety of progressive products and services that help customers effectively navigate the constantly changing Medicare Secondary Payer landscape.

“With more than 38 years of combined experience in the MSP compliance space, we are excited to bring the best of both organizations to this new endeavor,” added IMPAXX CEO, Jon Gunter. “IMPAXX will continue our unwavering commitment to facilitating successful outcomes while driving innovation for our customers through dynamic strategies, improved efficiencies, and leading-edge technologies.”